cobas SARS-CoV-2 & Influenza A/B Qualitative assay for use on the cobas 6800/8800 Systems; Materi...

FDA Device Recall #Z-1104-2023 - Class II, December 21, 2022

Recall Summary

Recall Number Z-1104-2023
Classification Class II - Moderate risk
Date Initiated December 21, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Molecular Systems, Inc.
Location Branchburg, NJ
Product Type Devices
Quantity 18,071 kits (US); 30,085 kits (OUS)

Product Description

cobas SARS-CoV-2 & Influenza A/B Qualitative assay for use on the cobas 6800/8800 Systems; Material number 09233474190

Reason for Recall

The firm received customer complaints regarding false negative Influenza A (Flu A) results and late Flu A Target Ct values. A false negative influenza A result may lead to additional testing, psychological distress, and delays to targeted therapy for influenza as well as true diagnosis.

Distribution Pattern

Domestic distribution nationwide. Foreign distribution worldwide.

Lot / Code Information

UDI-DI 00875197006674 All in-date lots

Other Recalls from Roche Molecular Systems, Inc.

Recall # Classification Product Date
Z-1106-2023 Class II cobas Influenza A/B & RSV UC (Utility Channel) ... Dec 21, 2022
Z-1105-2023 Class II cobas SARS-CoV-2 & Influenza A/B Qualitative nu... Dec 21, 2022
Z-0097-2023 Class II cobas 5800 instrument, Material No. 08707464001... Sep 8, 2022
Z-0828-2022 Class II cobas LiatSystem, respiratory virus panel nucle... Nov 16, 2021
Z-0083-2022 Class II cobas EGFR Mutation Test v2-Somatic gene mutati... Sep 3, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.